Angie’s List said Wednesday that it planned to sell roughly 8.8 million shares at $11 to $13 each.
The company, at the mid-point of the range, could raise$105.6 million. The company itself is offering 6.25 million shares, while selling stockholders, which includes senior management, are providing 2.5 million shares, according to an SEC filing. Angie’s List is expected to trade on the Nasdaq under the ticker “ANGI.”
BofA Merill Lynch is acting as bookrunner for the deal, while other underwriters include Allen & Co., Stifel Nicolaus Weisel and RBC Capital Markets. The underwriters have the option to buy an additional 1.3 million shares.